Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FSJQX vs. EMXC: which is better?

Bottom line

FSJQX vs EMXC: the short answer

FSJQX (Fidelity Series Emerging Markets ex China Index Fund) and EMXC (iShares MSCI Emerging Markets ex China ETF) are both mutual funds.

FSJQX is cheaper at 0.01% vs 0.25% — a difference of $24 a year per $10,000 invested.

Updated Nov 19, 2026

FSJQX vs EMXC side by side

FSJQXEMXC
TypeMutual fundETF
Fund familyFidelityiShares
CategoryEmerging MarketsEmerging Markets
Expense ratio0.01%0.25%
Annual cost per $10k$1$25
10-yr cost on $10k (prospectus)—$318
Max front load—None
12b-1 fee0%0%
1-yr return—+3.0%
5-yr return (annualized)—+3.9%
10-yr return (annualized)——
Best quarter—+25.4%
Worst quarter—−30.2%
Net assets (fund)—$24.6B
Number of holdings—667
Portfolio turnover—15%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

FSJQX and EMXC share none of their top holdings.

FSJQX top 10

    EMXC top 10

    1. Taiwan Semiconductor Manufacturing Company Limited — 17.94%
    2. Samsung Electronics Co., Ltd. — 9.75%
    3. SK hynix Inc. — 8.35%
    4. MediaTek Inc. — 2.04%
    5. Delta Electronics, Inc. — 1.47%
    6. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.18%
    7. Hon Hai Precision Industry Co., Ltd. — 1.13%
    8. Samsung Electronics Co., Ltd. — 1.07%
    9. Hdfc Bank Limited — 0.87%
    10. Reliance Industries Limited — 0.83%

    FAQ

    What is the difference between FSJQX and EMXC?
    FSJQX (Fidelity Series Emerging Markets ex China Index Fund) and EMXC (iShares MSCI Emerging Markets ex China ETF) are both mutual funds. FSJQX is cheaper at 0.01% vs 0.25% — a difference of $24 a year per $10,000 invested.
    Which is cheaper, FSJQX or EMXC?
    FSJQX has the lower expense ratio (0.01%).
    Should I own both FSJQX and EMXC?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.